Raising antibodies to a hapten (drug or steroid) requires that it be coupled to a carrier protein through a bridge such that the hapten has maximum exposure with minimum changes in its configuration. In raising antisera in six sheep against carbamazepine (CBZ) coupled to bovine albumin, we found that some subpopulations of the antibodies recognized the We then optimized and validated the assay for direct measurement of CBZ in serum or plasma. The antibodies are coupled to magnetizable particles, which greatly facilitates separation and ensures removal of endogenous interferents.
These were then used to study the effect of the hapten-fluorophore bridge configuration on various binding parameters and on assay sensitivity and specificity.
Materials and Methods

Materials
Reagents: 
Preparation Procedures
Carbamazepine-alkylamine derivatives: A mass spectrum revealed the expected molecular ion at mie 265 (C17H17N20). The other CBZ.alkylamine derivatives (FIgure 2) were prepared in the same way, except that we replaced ethylenediamine (ED) with 1,3-propanediamine (PD), 1,2-propane-. diamine (isopropyldiamine, IPD), or 1,6-hexanediamine (hexamethylenediamine, HI)). The infrared spectra of the resulting compounds were identical with that for CBZ-ED except that intensities of the C-H stretching bands increased with bridge length.
CBZ immunogen:
We dissolved 40 mg of CBZ-ED in 2.5 mL of pyridine, then added 60 mg of bovine albumin in 2.5 mL of distilled water and stirred while then adding 30mg of 
Anti-CBZ sera:
We immunized six mature female Border-Leicester-cross sheep according to a previously described protocol (19). We used the antiserum from the third bleeding of one animal in the studies described below. Figure  3) . 
Anti-CBZ
Results
Characterization of the CBZ-Albumin Conjugate
Optimization of Assay Conditions
We used an assay diluent buffer with a pH of 10. Precision:
We assessed precision by measuring each of three pools of selected patients' sera 10 times in one assay, giving mean values of 4, 8, and 16 mg of CBZ per liter, with within-assay CVs of 5.0, 2.0, and 1.5%, respectively. Measurement of the same specimens on 10 different days gave between-assay CVs of 8.0, 6.0, and 3.0%, respectively. We found the washing step to be necessary only for serum or plasma samples that were severely hemolyzed or icteric. Other drugs commonly administered with CBZ (listed above in the section on specificity)
and their major metabolites are nonfluorescent or fluoresce with spectra well removed from that of fluorescein, and they showed no contribution to the fluorescein signal in the final elution mixture.
Stability of reagents:
We observed no change in the properties of the CBZ tracers stored in ethanol at -20 #{176}C for two years.
The CBZ serum standards and the anti-CBZ magnetizable solid phase were also stable for at least a year at 4#{176}C.
Correlation with Other Assay Methods
Results for 50 patients' specimens assayed by gas-liquid chromatography in an independent laboratory were compared with our results by the present assay. The regression equation 
